Visibility Score
40/100
AI Mentions
74
AI Search Volume
10.0K
As of June 25, 2026, Autobio Diagnostics (autobio.com.cn) has an AI visibility score of 40 out of 100, based on 74 total AI mentions across platforms like Google AI Overview and ChatGPT. The brand generates 10.0K AI search volume. Compared to peers in the life sciences sector, Autobio Diagnostics ranks #7 of 7 in AI mention share of voice.
Autobio Diagnostics is a China-based medical diagnostics company in the IVD/Diagnostics segment, registered with the U.S. FDA. This report tracks how Autobio Diagnostics appears in AI search — ChatGPT, Google AI Overview and other answer engines.
AI Visibility Breakdown
Autobio Diagnostics has 74 total AI mentions across 2 tracked platforms, generating 10.0K in AI search volume. Google AI Overview accounts for the largest share at 88% of mentions.
By Platform
Brand Entities
No brand entity data available.
Where AI Sources Its Answers About Autobio Diagnostics
When AI assistants answer questions involving Autobio Diagnostics, these are the domains they most often cite. Winning AI visibility means being present and referenced on the sources the model actually reads — which is rarely a company's own website.
Share of Voice vs Competitors
Autobio Diagnostics ranks #7 out of 7 competitors in AI mention share of voice, capturing 0% of total mentions. Thermo Fisher Scientific leads with 55.2K AI mentions. Competitors tracked include Thermo Fisher Scientific, Roche Diagnostics, QIAGEN, Agilent Technologies.
AI Mentions
Comparison
| Company | Mentions | AI Vol |
|---|---|---|
| autobio.com.cn (You) | 74 | 10.0K |
| thermofisher.com (Thermo Fisher Scientific) | 55.2K | 29.5M |
| roche.com (Roche Diagnostics) | 5.9K | 2.0M |
| qiagen.com (QIAGEN) | 5.8K | 2.9M |
| agilent.com (Agilent Technologies) | 5.0K | 2.0M |
| bio-rad.com (Bio-Rad Laboratories) | 4.2K | 1.6M |
| grifols.com (Grifols) | 3.5K | 6.5M |
Improve your brand's AI visibility
This is a static snapshot. VayoMed helps life sciences brands monitor AI mentions, track competitors, and build the content and citation signals that make AI platforms more likely to recommend them.